Table 2.
Estimated Overall Change of DACON 6 Months after Introduction of Reformulated Oxycodone CR from Interrupted Time Series Models
| Medication strength | Overall change (intercept + slope) 6 months after introduction | P value | |
|---|---|---|---|
| Daily tablets | Change, % | ||
| Oxycodone CR | |||
| All strengths | −0.11 | −3.7 | <.001 |
| Highest strength | 0.07 | 2.1 | .003 |
| Lower strengths | −0.09 | −3.4 | <.001 |
| Oxymorphone ER | |||
| All strengths | 0.02 | 0.7 | .611 |
| Highest strength | 0.07 | 2.3 | .236 |
| Lower strengths | −0.03 | −1.4 | .087 |
CR indicates controlled release; DACON, daily average consumption; ER, extended release.